Stay updated on Pembrolizumab in SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in SCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4, indicating a new version of the page content has been published.
    Difference
    0.1%
    Check dated 2026-05-17T11:12:04.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s ClinicalTrials.gov interface revision indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-25T18:45:29.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T13:38:59.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added the keyword 'Small cell lung carcinoma' and included a Resources section linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-03-27T23:53:40.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 in the page header.
    Difference
    0.1%
    Check dated 2026-03-20T19:59:50.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T17:58:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in SCLC Clinical Trial page.